Accelerate Diagnostics Stock Forecast - Naive Prediction
| AXDXDelisted Stock | USD 0.04 0.02 164.90% |
Accelerate Stock outlook is based on your current time horizon.
At this time the value of rsi of Accelerate Diagnostics' share price is below 20 . This suggests that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 19
Sell Peaked
Oversold | Overbought |
Using Accelerate Diagnostics hype-based prediction, you can estimate the value of Accelerate Diagnostics from the perspective of Accelerate Diagnostics response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Accelerate Diagnostics on the next trading day is expected to be -0.31 with a mean absolute deviation of 0.06 and the sum of the absolute errors of 3.61. Accelerate Diagnostics after-hype prediction price | USD 0.04 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Accelerate |
Accelerate Diagnostics Additional Predictive Modules
Most predictive techniques to examine Accelerate price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Accelerate using various technical indicators. When you analyze Accelerate charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Accelerate Diagnostics Naive Prediction Price Forecast For the 30th of January
Given 90 days horizon, the Naive Prediction forecasted value of Accelerate Diagnostics on the next trading day is expected to be -0.31 with a mean absolute deviation of 0.06, mean absolute percentage error of 0.01, and the sum of the absolute errors of 3.61.Please note that although there have been many attempts to predict Accelerate Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Accelerate Diagnostics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Accelerate Diagnostics Stock Forecast Pattern
| Backtest Accelerate Diagnostics | Accelerate Diagnostics Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Accelerate Diagnostics stock data series using in forecasting. Note that when a statistical model is used to represent Accelerate Diagnostics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 112.8922 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0591 |
| MAPE | Mean absolute percentage error | 0.2667 |
| SAE | Sum of the absolute errors | 3.6051 |
Predictive Modules for Accelerate Diagnostics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Accelerate Diagnostics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Accelerate Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Accelerate Diagnostics After-Hype Price Density Analysis
As far as predicting the price of Accelerate Diagnostics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Accelerate Diagnostics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Accelerate Diagnostics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Accelerate Diagnostics Estimiated After-Hype Price Volatility
In the context of predicting Accelerate Diagnostics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Accelerate Diagnostics' historical news coverage. Accelerate Diagnostics' after-hype downside and upside margins for the prediction period are 0.04 and 0.04, respectively. We have considered Accelerate Diagnostics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Accelerate Diagnostics is very steady at this time. Analysis and calculation of next after-hype price of Accelerate Diagnostics is based on 3 months time horizon.
Accelerate Diagnostics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Accelerate Diagnostics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Accelerate Diagnostics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Accelerate Diagnostics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 6 Events / Month | 1 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.04 | 0.04 | 0.00 |
|
Accelerate Diagnostics Hype Timeline
Accelerate Diagnostics is presently traded for 0.04. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Accelerate is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at 0.0%. %. The volatility of related hype on Accelerate Diagnostics is about 0.0%, with the expected price after the next announcement by competition of 0.04. About 38.0% of the company shares are held by company insiders. The company recorded a loss per share of 2.15. Accelerate Diagnostics had not issued any dividends in recent years. The entity had 1:10 split on the 12th of July 2023. Given the investment horizon of 90 days the next forecasted press release will be in about 6 days. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates.Accelerate Diagnostics Related Hype Analysis
Having access to credible news sources related to Accelerate Diagnostics' direct competition is more important than ever and may enhance your ability to predict Accelerate Diagnostics' future price movements. Getting to know how Accelerate Diagnostics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Accelerate Diagnostics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PAVM | PAVmed Inc | 0.64 | 9 per month | 7.67 | (0) | 10.86 | (10.69) | 111.24 | |
| BIOL | BIOLASE | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NEPTF | Neptune Wellness Solutions | 0.00 | 0 per month | 0.00 | 0.08 | 0.00 | 0.00 | 399.00 | |
| ACOR | Acorda Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| IMPL | Impel Neuropharma | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| INFIQ | Infinity Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| LSDI | Lucy Scientific Discovery | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CYTH | Cyclo Therapeutics | (0.04) | 8 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| HTGMQ | HTG Molecular Diagnostics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BLCM | Bellicum Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accelerate Diagnostics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Accelerate Diagnostics stock to make a market-neutral strategy. Peer analysis of Accelerate Diagnostics could also be used in its relative valuation, which is a method of valuing Accelerate Diagnostics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Accelerate Diagnostics Market Strength Events
Market strength indicators help investors to evaluate how Accelerate Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Accelerate Diagnostics shares will generate the highest return on investment. By undertsting and applying Accelerate Diagnostics stock market strength indicators, traders can identify Accelerate Diagnostics entry and exit signals to maximize returns.
Story Coverage note for Accelerate Diagnostics
The number of cover stories for Accelerate Diagnostics depends on current market conditions and Accelerate Diagnostics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Accelerate Diagnostics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Accelerate Diagnostics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Accelerate Diagnostics Short Properties
Accelerate Diagnostics' future price predictability will typically decrease when Accelerate Diagnostics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Accelerate Diagnostics often depends not only on the future outlook of the potential Accelerate Diagnostics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Accelerate Diagnostics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 23.3 M | |
| Cash And Short Term Investments | 16.3 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in Accelerate Stock
If you are still planning to invest in Accelerate Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Accelerate Diagnostics' history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |